Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries. 

Cardiology is the medical speciality with the second most FDA clearances overall. 

Healthcare companies from all over the world are showing off their newest cardiovascular offerings at CES 2025 in Las Vegas.

Dynocardia has now received nearly $5.1 million in funding from the NHLBI to help speed commercializing its wrist-worn monitor to avoid the need for invasive catheter BP monitoring.

The new report could go on to help guide decisions made by CMS and hospital leadership teams for years to come.

Cardiologists and other physicians may soon need to provide much more information when ordering remote patient monitoring for Medicare patients.

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

Medtronic and Abbott are often seen as rivals in a competitive marketplace, but the two companies are collaborating with a simple goal in mind: improving patient access to high-quality CGM devices.